Company Filing History:
Years Active: 2025
Title: Hui-Jeon Jeon: Innovator in Biomaterials and Pharmaceutical Applications
Introduction
Hui-Jeon Jeon is an inventor based in Daegu, South Korea. He has made significant contributions to the field of biomaterials and pharmaceuticals. Although he currently holds no granted patents, his work is focused on innovative methods for preparing biomaterials and pharmaceutical compositions.
Latest Patent Applications
Hui-Jeon Jeon has filed several notable patent applications. One of his latest applications is titled "Novel Compound, Preparation Method Thereof, and Use Thereof." This invention relates to a method for preparing a biomaterial that has selectively functionalized tyrosine. The method allows for high-yield coupling of a specific compound to tyrosine, ensuring that the inherent activity of the biomaterial is maintained. This biomaterial can be effectively used as a pharmaceutical composition containing a drug as an active ingredient.
Another significant application is for a "Pyrrolidine Derivative, and Pharmaceutical Composition for Preventing or Treating Beta-Amyloid or Tau Protein-Associated Diseases Containing Same." This application provides a novel pyrrolidine derivative that has the potential to inhibit beta-amyloid and tau protein aggregation. It also aims to prevent and treat diseases associated with these proteins.
Conclusion
Hui-Jeon Jeon is an innovative inventor whose work in biomaterials and pharmaceuticals shows great promise. His latest patent applications reflect his commitment to advancing medical science and improving therapeutic options.